CSX vs LAB · P/E 19, rev $14.09B vs rev $174.4M
CSX Corporation (CSX) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. LAB currently screens at market cap $317.1M.
Not investment advice. Open the CSX and LAB stock pages for the full models.
Not investment advice.